Literature DB >> 11955521

Mutation of the GABAA receptor M1 transmembrane proline increases GABA affinity and reduces barbiturate enhancement.

L John Greenfield1, Shahid H Zaman, Margaret L Sutherland, Sarah C R Lummis, María-Isabel Niemeyer, Eric A Barnard, Robert L Macdonald.   

Abstract

All GABA(A) receptor (GABAR) subunits include an invariant proline in a consensus motif in the first transmembrane segment (M1). In receptors containing bovine alpha1, beta1 and gamma2 subunits, we analyzed the effect of mutating this M1 proline to alanine in the alpha1 or beta1 subunit using 3 different expression systems. The beta1 subunit mutant, beta1(P228A), reduced the EC(50) for GABA about 10-fold in whole cell recordings in HEK293 cells and L929 fibroblasts. The corresponding alpha1 subunit mutant (alpha1(P233A)) also reduced the GABA EC(50) when expressed in Xenopus oocytes; alpha1(P233A)beta1gamma2S receptors failed to assemble in HEK293 cells. Binding of [(3)H]flumazenil and [(3)H]muscimol to transfected HEK293 cell membranes showed similar levels of receptor expression with GABARs containing beta1 or beta1(P228A) subunits and no change in the affinity for [(3)H]flumazenil; however, the affinity for [(3)H]muscimol was increased 6-fold in GABARs containing beta1(P228A) subunits. In L929 cells, presence of the beta1(P228A) subunit reduced enhancement by barbiturates without affecting enhancement by diazepam or alfaxalone. Single channel recordings from alpha1beta1gamma2S and alpha1beta1(P228A)gamma2L GABARs showed similar channel kinetics, but beta-mutant containing receptors opened at lower GABA concentrations. We conclude that the beta1 subunit M1 segment proline affects the linkage between GABA binding and channel gating and is critical for barbiturate enhancement. Mutation of the M1 proline in the alpha1 subunit also inhibited receptor assembly.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955521     DOI: 10.1016/s0028-3908(01)00196-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  13 in total

1.  GABRG2 gene polymorphisms in Egyptian children with simple febrile seizures.

Authors:  Sanaa M Abdel Salam; Hadeel M A Rahman; Rehab A Karam
Journal:  Indian J Pediatr       Date:  2011-10-08       Impact factor: 1.967

2.  Barbiturates require the N terminus and first transmembrane domain of the delta subunit for enhancement of alpha1beta3delta GABAA receptor currents.

Authors:  Hua-Jun Feng; Robert L Macdonald
Journal:  J Biol Chem       Date:  2010-06-04       Impact factor: 5.157

3.  Number and locations of agonist binding sites required to activate homomeric Cys-loop receptors.

Authors:  Diego Rayes; María José De Rosa; Steven M Sine; Cecilia Bouzat
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

4.  Tryptophan mutations at azi-etomidate photo-incorporation sites on alpha1 or beta2 subunits enhance GABAA receptor gating and reduce etomidate modulation.

Authors:  Deirdre Stewart; Rooma Desai; Qi Cheng; Aiping Liu; Stuart A Forman
Journal:  Mol Pharmacol       Date:  2008-09-19       Impact factor: 4.436

5.  Molecular determinants of ivermectin sensitivity at the glycine receptor chloride channel.

Authors:  Timothy Lynagh; Timothy I Webb; Christine L Dixon; Brett A Cromer; Joseph W Lynch
Journal:  J Biol Chem       Date:  2011-10-27       Impact factor: 5.157

6.  Cysteine substitutions define etomidate binding and gating linkages in the α-M1 domain of γ-aminobutyric acid type A (GABAA) receptors.

Authors:  Deirdre S Stewart; Mayo Hotta; Guo-Dong Li; Rooma Desai; David C Chiara; Richard W Olsen; Stuart A Forman
Journal:  J Biol Chem       Date:  2013-09-05       Impact factor: 5.157

7.  A Multifaceted GABAA Receptor Modulator: Functional Properties and Mechanism of Action of the Sedative-Hypnotic and Recreational Drug Methaqualone (Quaalude).

Authors:  Harriet Hammer; Benjamin M Bader; Corina Ehnert; Christoffer Bundgaard; Lennart Bunch; Kirsten Hoestgaard-Jensen; Olaf H-U Schroeder; Jesper F Bastlund; Alexandra Gramowski-Voß; Anders A Jensen
Journal:  Mol Pharmacol       Date:  2015-06-08       Impact factor: 4.436

8.  General anesthetic actions on GABA(A) receptors.

Authors:  Paul S Garcia; Scott E Kolesky; Andrew Jenkins
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

9.  Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.

Authors:  David C Chiara; Selwyn S Jayakar; Xiaojuan Zhou; Xi Zhang; Pavel Y Savechenkov; Karol S Bruzik; Keith W Miller; Jonathan B Cohen
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

Review 10.  Molecular mechanisms of antiseizure drug activity at GABAA receptors.

Authors:  L John Greenfield
Journal:  Seizure       Date:  2013-05-14       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.